| Bioactivity | Sulfamerazine (RP-2632) is a sulfonamide antibacterial. Sulfamerazine, the monomethyl derivative of sulfadiazine, is 2-sulfanilamido-4-methylpyrimidine. Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthesizes[1]. | ||||||||||||
| Invitro | Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA[1]. | ||||||||||||
| Name | Sulfamerazine | ||||||||||||
| CAS | 127-79-7 | ||||||||||||
| Formula | C11H12N4O2S | ||||||||||||
| Molar Mass | 264.30 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Sulfamerazine
CAS: 127-79-7 F: C11H12N4O2S W: 264.30
Sulfamerazine (RP-2632) is a sulfonamide antibacterial. Sulfamerazine, the monomethyl derivative of sulfadiazine, is 2-s
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.